Androgen receptor footprint on the way to prostate cancer progression Myles C. HodgsonWayne A. BowdenIrina U. Agoulnik Topic Paper Open access 17 September 2011 Pages: 279 - 285
Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives Nagalakshmi NadimintyAllen C. Gao Topic paper 19 October 2011 Pages: 287 - 295
Androgen receptor co-activators in the regulation of cellular events in prostate cancer Zoran CuligFrédéric R. Santer Topic paper 22 November 2011 Pages: 297 - 302
NF-κB signaling in prostate cancer: A promising therapeutic target? Garima JainMarcus V. CronauerRalf B. Marienfeld Topic paper 16 November 2011 Pages: 303 - 310
Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer Marianne D. Sadar Topic Paper 11 August 2011 Pages: 311 - 318
ID4 is frequently downregulated and partially hypermethylated in prostate cancer Anna VinarskajaWolfgang GoeringWolfgang A. Schulz Topic paper 01 September 2011 Pages: 319 - 325
Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells Matthias B. StopeTina SchubertMartin Burchardt Topic Paper 24 February 2012 Pages: 327 - 331
AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR variants in prostate cancer cells Wolfgang StreicherFriedemann ZengerlingMarcus V. Cronauer Topic Paper 24 February 2012 Pages: 333 - 339
Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: a retrospective data analysis Friedrich AignerGeorg SchäferFerdinand Frauscher Topic Paper 18 December 2011 Pages: 341 - 346
When is it necessary to perform nuclear renogram in patients with a unilateral neonatal hydronephrosis? Berk BurguOzgu AydogduDuncan Wilcox Original Article 06 August 2011 Pages: 347 - 352
Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma B. AmendJ. HennenlotterJ. Bedke Original Article 07 August 2011 Pages: 353 - 359
Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy Eduard García-CruzJorge HuguetAntonio Alcaraz Original Article 11 August 2011 Pages: 361 - 365
Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment S. H. AlloussiCh. LangS. Alloussi Original Article 13 August 2011 Pages: 367 - 373
The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy Ryo KishimotoTakashi SaikaHiromi Kumon Original Article 17 August 2011 Pages: 375 - 378
Oncologic outcomes following radical prostatectomy with intraoperative cell salvage Michael A. GorinAhmed EldefrawyMark S. Soloway Original Article 17 August 2011 Pages: 379 - 383
Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome Paul AbramsChristopher R. ChappleSteven Sharpe Original Article 19 August 2011 Pages: 385 - 392
Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy Julien SerorDavid R. YatesMorgan Rouprêt Original Article 20 August 2011 Pages: 393 - 398
Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases Marcus SchenckTim SchneiderAndreas Eisenhardt Original Article 28 August 2011 Pages: 399 - 404
Age-specific PCA3 score reference values for diagnosis of prostate cancer Tobias KlatteMatthias WaldertMesut Remzi Original Article 30 August 2011 Pages: 405 - 410
Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC) Thilo SchwalenbergJens-Uwe StolzenburgJochen Neuhaus Original Article 30 August 2011 Pages: 411 - 417
Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia Richard-Olivier FourcadeFrançois LacoinFrançois-Emery Cotté Original Article Open access 03 September 2011 Pages: 419 - 426